Pharmarise Holdings Corporation (2796.T)
JPY 563.0
(-2.26%)
JPY 563.0
(-2.26%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 7.53 Billion JPY | 4.2% |
| 2022 | 6.69 Billion JPY | 1.5% |
| 2021 | 6.59 Billion JPY | -3.3% |
| 2020 | 6.82 Billion JPY | 6.54% |
| 2019 | 6.4 Billion JPY | -4.48% |
| 2018 | 6.7 Billion JPY | -1.02% |
| 2017 | 6.77 Billion JPY | -0.06% |
| 2016 | 6.77 Billion JPY | 10.76% |
| 2015 | 6.11 Billion JPY | 16.9% |
| 2014 | 5.23 Billion JPY | 17.85% |
| 2013 | 4.44 Billion JPY | 25.76% |
| 2012 | 3.53 Billion JPY | 26.34% |
| 2011 | 2.79 Billion JPY | 7.21% |
| 2010 | 2.6 Billion JPY | 17.91% |
| 2009 | 2.21 Billion JPY | 13.16% |
| 2008 | 1.95 Billion JPY | 12.91% |
| 2007 | 1.73 Billion JPY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 2.08 Billion JPY | 15.89% |
| 2023 Q2 | 1.76 Billion JPY | -2.11% |
| 2023 Q1 | 1.79 Billion JPY | 13.93% |
| 2023 Q4 | 1.8 Billion JPY | -4.86% |
| 2023 Q3 | 1.89 Billion JPY | 7.44% |
| 2023 FY | 6.97 Billion JPY | 4.2% |
| 2022 Q3 | 1.7 Billion JPY | 2.47% |
| 2022 FY | 6.69 Billion JPY | 1.5% |
| 2022 Q1 | 1.74 Billion JPY | 14.24% |
| 2022 Q2 | 1.66 Billion JPY | -4.92% |
| 2022 Q4 | 1.57 Billion JPY | -7.34% |
| 2021 Q4 | 1.53 Billion JPY | -10.36% |
| 2021 Q3 | 1.7 Billion JPY | 4.4% |
| 2021 Q2 | 1.63 Billion JPY | -4.94% |
| 2021 Q1 | 1.72 Billion JPY | -1.66% |
| 2021 FY | 6.59 Billion JPY | -3.3% |
| 2020 Q2 | 1.57 Billion JPY | -7.48% |
| 2020 FY | 6.82 Billion JPY | 6.54% |
| 2020 Q4 | 1.75 Billion JPY | -2.89% |
| 2020 Q1 | 1.69 Billion JPY | 9.27% |
| 2020 Q3 | 1.8 Billion JPY | 14.7% |
| 2019 Q2 | 1.48 Billion JPY | -12.95% |
| 2019 Q1 | 1.7 Billion JPY | 1.61% |
| 2019 FY | 6.4 Billion JPY | -4.48% |
| 2019 Q4 | 1.55 Billion JPY | -6.1% |
| 2019 Q3 | 1.65 Billion JPY | 11.37% |
| 2018 Q4 | 1.68 Billion JPY | 0.66% |
| 2018 FY | 6.7 Billion JPY | -1.02% |
| 2018 Q3 | 1.66 Billion JPY | 3.54% |
| 2018 Q2 | 1.61 Billion JPY | -7.41% |
| 2018 Q1 | 1.74 Billion JPY | 3.57% |
| 2017 FY | 6.77 Billion JPY | -0.06% |
| 2017 Q3 | 1.68 Billion JPY | 5.97% |
| 2017 Q1 | 1.81 Billion JPY | -2.68% |
| 2017 Q2 | 1.59 Billion JPY | -12.24% |
| 2017 Q4 | 1.68 Billion JPY | -0.3% |
| 2016 Q3 | 1.64 Billion JPY | 6.87% |
| 2016 Q1 | 1.72 Billion JPY | 5.3% |
| 2016 Q2 | 1.54 Billion JPY | -10.29% |
| 2016 Q4 | 1.86 Billion JPY | 12.98% |
| 2016 FY | 6.77 Billion JPY | 10.76% |
| 2015 Q2 | 1.4 Billion JPY | -2.82% |
| 2015 FY | 6.11 Billion JPY | 16.9% |
| 2015 Q1 | 1.44 Billion JPY | 5.8% |
| 2015 Q4 | 1.63 Billion JPY | -0.17% |
| 2015 Q3 | 1.63 Billion JPY | 16.61% |
| 2014 Q3 | 1.3 Billion JPY | 1.35% |
| 2014 Q4 | 1.36 Billion JPY | 4.5% |
| 2014 Q2 | 1.28 Billion JPY | 1.22% |
| 2014 Q1 | 1.27 Billion JPY | -5.66% |
| 2014 FY | 5.23 Billion JPY | 17.85% |
| 2013 Q2 | 1.03 Billion JPY | 0.93% |
| 2013 Q3 | 1.03 Billion JPY | -0.12% |
| 2013 FY | 4.44 Billion JPY | 25.76% |
| 2013 Q4 | 1.34 Billion JPY | 30.7% |
| 2013 Q1 | 1.02 Billion JPY | -7.36% |
| 2012 Q3 | 912.96 Million JPY | 23.29% |
| 2012 Q2 | 740.51 Million JPY | -4.0% |
| 2012 Q1 | 771.37 Million JPY | 3.52% |
| 2012 FY | 3.53 Billion JPY | 26.34% |
| 2012 Q4 | 1.1 Billion JPY | 21.1% |
| 2011 Q4 | 745.17 Million JPY | 1.48% |
| 2011 FY | 2.79 Billion JPY | 7.21% |
| 2011 Q2 | 645.46 Million JPY | -3.59% |
| 2011 Q3 | 734.27 Million JPY | 13.76% |
| 2011 Q1 | 669.5 Million JPY | 4.11% |
| 2010 Q3 | 660.8 Million JPY | 6.46% |
| 2010 Q4 | 643.1 Million JPY | -2.68% |
| 2010 FY | 2.6 Billion JPY | 17.91% |
| 2010 Q1 | 681.82 Million JPY | 9.68% |
| 2010 Q2 | 620.73 Million JPY | -8.96% |
| 2009 Q2 | 469.16 Million JPY | -11.08% |
| 2009 Q3 | 592.12 Million JPY | 26.21% |
| 2009 FY | 2.21 Billion JPY | 13.16% |
| 2009 Q1 | 527.63 Million JPY | 2.72% |
| 2009 Q4 | 621.64 Million JPY | 4.99% |
| 2008 Q3 | 495.34 Million JPY | 3.93% |
| 2008 FY | 1.95 Billion JPY | 12.91% |
| 2008 Q2 | 476.61 Million JPY | 0.0% |
| 2008 Q4 | 513.68 Million JPY | 3.7% |
| 2007 FY | 1.73 Billion JPY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| HEARTSEED INC | 1.8 Billion JPY | -317.494% |
| Cawachi Limited | 58.2 Billion JPY | 87.057% |
| Qol Holdings Co., Ltd. | 14.92 Billion JPY | 49.531% |
| MatsukiyoCocokara & Co. | 278.39 Billion JPY | 97.294% |
| Welcia Holdings Co., Ltd. | 326.87 Billion JPY | 97.695% |
| Create SD Holdings Co., Ltd. | 85.11 Billion JPY | 91.149% |
| NIHON CHOUZAI Co.,Ltd. | 48.09 Billion JPY | 84.337% |
| COSMOS Pharmaceutical Corporation | 156.8 Billion JPY | 95.196% |
| Tsuruha Holdings Inc. | 263.07 Billion JPY | 97.137% |
| Ohki Healthcare Holdings Co.,Ltd. | 14.84 Billion JPY | 49.262% |
| Satudora Holdings Co.,Ltd. | 20.92 Billion JPY | 64.0% |
| Kusuri No Aoki Holdings Co., Ltd. | 99.52 Billion JPY | 92.431% |
| Medical System Network Co., Ltd. | 44.09 Billion JPY | 82.916% |
| Shinnihonseiyaku Co., Ltd. | 26.55 Billion JPY | 71.636% |
| Sugi Holdings Co.,Ltd. | 192.21 Billion JPY | 96.081% |
| YAKUODO HOLDINGS Co., Ltd. | 22.65 Billion JPY | 66.742% |
| Astena Holdings Co., Ltd. | 14.04 Billion JPY | 46.361% |
| Genky DrugStores Co., Ltd. | 28.6 Billion JPY | 73.666% |
| Ain Holdings Inc. | 39.09 Billion JPY | 80.73% |
| Sundrug Co.,Ltd. | 148.32 Billion JPY | 94.921% |